Lonsurf
Generic name: Tipiracil And Trifluridine Combination Tablet
Dosage form: oral tablet
Drug class:
Antineoplastic combinations
Usage of Lonsurf
Lonsurf is an oral combination tablet that contains tipiracil and trifluridine. Tipiracil and trifluridine are anti-cancer medicines that interfere with the growth and spread of cancer cells in the body.
Lonsurf may be used to treat adults with:
Lonsurf was first FDA-approved on February 23, 2015.
Lonsurf side effects
Get emergency medical help if you have signs of an allergic reaction to Lonsurf: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Serious side effects may be more likely in older adults.
Common Lonsurf side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Lonsurf
To make sure Lonsurf is safe for you, tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
The dosage may need to be reduced in severe kidney disease. Do not use Lonsurf in patients with moderate or severe liver disease.
People over the age of 65 years are more likely to develop blood abnormalities and other side effects from Lonsurf.
Tipiracil and trifluridine can harm an unborn baby if the mother or the father is using this medicine.
You should not breastfeed while using this medicine, and for at least 24 hours after your last dose.
Relate drugs
- Akeega
- Cytarabine and daunorubicin liposomal
- Cedazuridine and decitabine
- Daunorubicin and cytarabine liposome
- Decitabine and cedazuridine
- Inqovi
- Kisqali Femara Co-Pack
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Letrozole and ribociclib
- Lonsurf
- Niraparib and abiraterone
- Nivolumab and relatlimab
- Nivolumab/relatlimab-rmbw
- Opdualag
- Ribociclib and letrozole
- Tipiracil and trifluridine
- Trifluridine and tipiracil
- Vyxeos
- Vyxeos liposomal
How to use Lonsurf
Take Lonsurf exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.
Before and during treatment with this medicine, you will need blood tests. The timing of these tests is very important.
The recommended dosage of Lonsurf is based on your body surface area (calculated by using your height and weight). It is usually dosed at 35 mg/m2/dose, given orally (by mouth) twice a day. Your doctor will calculate the right dose for you and your dosage may change if you gain or lose weight.
Warnings
There are no contraindications to the use of Lonsurf.
Lonsurf affects your immune system and can cause serious bone marrow suppression. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, body aches, or unusual bleeding or bruising.
You will need blood tests before and during treatment with Lonsurf, before and on Day 15 of each cycle. Call your doctor at once if you develop signs of infection (fever, chills, body aches). The dosage of Lonsurf may need to be reduced.
Lonsurf should not be given to pregnant women because it can harm an unborn baby. If you are a female of reproductive potential your doctor may ask you to take a pregnancy test before starting Lonsurf. You should use effective contraception while taking it.
What other drugs will affect Lonsurf
Other drugs may interact with tipiracil and trifluridine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions